BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 9934652)

  • 1. Mammographic parenchymal patterns and mode of detection: implications for the breast screening programme.
    Sala E; Warren R; McCann J; Duffy S; Day N; Luben R
    J Med Screen; 1998; 5(4):207-12. PubMed ID: 9934652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Size, node status and grade of breast tumours: association with mammographic parenchymal patterns.
    Sala E; Solomon L; Warren R; McCann J; Duffy S; Luben R; Day N
    Eur Radiol; 2000; 10(1):157-61. PubMed ID: 10663736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mammographic parenchymal patterns and breast cancer natural history--a case-control study.
    Sala E; Warren R; McCann J; Duffy S; Luben R; Day N
    Acta Oncol; 2001; 40(4):461-5. PubMed ID: 11504304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mammographic parenchymal patterns and breast cancer risk. A case control study of a population-based screening experience.
    Ciatto S; Bravetti P; Cecchini S; Cirillo A
    Radiol Med; 1990 Apr; 79(4):346-8. PubMed ID: 2377751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of mammographic parenchymal pattern in screening-detected and interval invasive breast cancers on pathologic features, mammographic features, and patient survival.
    Porter GJ; Evans AJ; Cornford EJ; Burrell HC; James JJ; Lee AH; Chakrabarti J
    AJR Am J Roentgenol; 2007 Mar; 188(3):676-83. PubMed ID: 17312053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mammographic features and breast cancer risk: effects with time, age, and menopause status.
    Byrne C; Schairer C; Wolfe J; Parekh N; Salane M; Brinton LA; Hoover R; Haile R
    J Natl Cancer Inst; 1995 Nov; 87(21):1622-9. PubMed ID: 7563205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor characteristics associated with mammographic detection of breast cancer in the Ontario breast screening program.
    Kirsh VA; Chiarelli AM; Edwards SA; O'Malley FP; Shumak RS; Yaffe MJ; Boyd NF
    J Natl Cancer Inst; 2011 Jun; 103(12):942-50. PubMed ID: 21540443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of breast cancer and changes in mammographic parenchymal patterns over time.
    Salminen TM; Saarenmaa IE; Heikkilä MM; Hakama M
    Acta Oncol; 1998; 37(6):547-51. PubMed ID: 9860312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is a dense mammographic parenchymal pattern a contraindication to hormonal replacement therapy?
    Salminen TM; Saarenmaa IE; Heikkilä MM; Hakama M
    Acta Oncol; 2000; 39(8):969-72. PubMed ID: 11207004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective study of the value of mammographic patterns as indicators of breast cancer risk in a screening experience.
    Ciatto S; Zappa M
    Eur J Radiol; 1993 Sep; 17(2):122-5. PubMed ID: 8223680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary estrogen metabolites and mammographic parenchymal patterns in postmenopausal women.
    Riza E; dos Santos Silva I; De Stavola B; Bradlow HL; Sepkovic DW; Linos D; Linos A
    Cancer Epidemiol Biomarkers Prev; 2001 Jun; 10(6):627-34. PubMed ID: 11401912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mammographic parenchymal patterns as indicators of breast cancer risk.
    Saftlas AF; Wolfe JN; Hoover RN; Brinton LA; Schairer C; Salane M; Szklo M
    Am J Epidemiol; 1989 Mar; 129(3):518-26. PubMed ID: 2916545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wolfe's parenchymal pattern and percentage of the breast with mammographic densities: redundant or complementary classifications?
    Brisson J; Diorio C; Mâsse B
    Cancer Epidemiol Biomarkers Prev; 2003 Aug; 12(8):728-32. PubMed ID: 12917203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percentage density, Wolfe's and Tabár's mammographic patterns: agreement and association with risk factors for breast cancer.
    Gram IT; Bremnes Y; Ursin G; Maskarinec G; Bjurstam N; Lund E
    Breast Cancer Res; 2005; 7(5):R854-61. PubMed ID: 16168132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mammographic density and structural features can individually and jointly contribute to breast cancer risk assessment in mammography screening: a case-control study.
    Winkel RR; von Euler-Chelpin M; Nielsen M; Petersen K; Lillholm M; Nielsen MB; Lynge E; Uldall WY; Vejborg I
    BMC Cancer; 2016 Jul; 16():414. PubMed ID: 27387546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel mammographic image features differentiate between interval and screen-detected breast cancer: a case-case study.
    Strand F; Humphreys K; Cheddad A; Törnberg S; Azavedo E; Shepherd J; Hall P; Czene K
    Breast Cancer Res; 2016 Oct; 18(1):100. PubMed ID: 27716311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast cancer screening by mammography in women aged under 50 years in Japan.
    Morimoto T; Sasa M; Yamaguchi T; Kondo H; Akaiwa H; Sagara Y
    Anticancer Res; 2000; 20(5C):3689-94. PubMed ID: 11268440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unfavourable change in mammographic patterns and the breast cancer risk factors.
    Salminen TM; Saarenmaa IE; Heikkilä MM; Hakama M
    Breast Cancer Res Treat; 1999 Sep; 57(2):165-73. PubMed ID: 10598043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Favorable change in mammographic parenchymal patterns and breast cancer risk factors.
    Salminen T; Hakama M; Heikkilä M; Saarenmaa I
    Int J Cancer; 1998 Nov; 78(4):410-4. PubMed ID: 9797126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of patterns of hormone replacement therapy use and mammographic density on breast cancer detection.
    Chiarelli AM; Kirsh VA; Klar NS; Shumak R; Jong R; Fishell E; Yaffe MJ; Boyd NF
    Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1856-62. PubMed ID: 17035392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.